COCHW Envoy Medical, Inc Warrant

XNAS
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

COCHW — —
Key stats
About
Industry (SIC)
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES (3842) · industry map
Exchange
XNAS
Employees
47
List Date
2023-10-02
CIK
0001840877
Headquarters
White Bear Lake, MN
Homepage
https://www.envoymedical.com

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'23'24'25'26Avg
Jan---15.84%-18.37%-6.60%-13.60%
Feb--788.89%11.84%33.68%278.14%
Mar---40.83%-7.30%65.17%5.68%
Apr--9.16%25.84%-5.01%10.00%
May---64.50%62.25%-33.76%-12.00%
Jun--11.11%-29.40%-7.14%-8.48%
Jul---18.54%-0.20%-39.52%-19.42%
Aug--50.00%-12.50%17.65%18.38%
Sep--6.81%-10.48%-21.64%-8.44%
Oct-81.06%-41.57%15.67%-16.33%*-30.82%
Nov83.33%-41.74%40.17%--27.25%
Dec-11.50%-41.62%-23.12%---25.41%
Total-69.27%-50.57%18.87%-43.79%-36.19%
* Only 4 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $0.04
SMA 50: $0.04
SMA 200: $0.05
Current: $0.03
EMA 12: $0.03
EMA 26: $0.04
MACD: -0.0031 | Signal: -0.0011
BEARISH
ADX (14): 13.84
RANGE
+DI: 26.72
−DI: 24.88

Momentum Oscillators

RSI (14): 43.32
NEUTRAL
Stoch %K: 14.99
Stoch %D: 13.44
Williams %R: -100.00

Volume & Volatility

BB Upper: $0.05
BB Lower: $0.02
NEUTRAL
OBV: 3,148,466
Vol SMA 20: 34,800
Vol ROC: -93.45%
ATR: $0.01
True Range: $0.00
HV 20: 342.6%
HV 30: 366.9%
HV 60: 353.8%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2023-11-10T00:00:00 – 2026-10-30T00:00:00
AI Analysis

LLM Stock Analysis Report: COCHW

Executive Summary

Overall Assessment: NEUTRAL (Confidence Level: 6/10)

Key Drivers:

  • Technical signals indicate a range-bound market with neutral momentum
  • Recent news headlines are mixed, but the FDA approval is a positive catalyst
  • Low volatility and beta suggest a defensive posture

Primary Risks:

  • Lack of strong technical momentum or sentiment indicators
  • Uncertainty around earnings release and potential catalysts

Investment Thesis: COCHW's low volatility and range-bound market may provide an opportunity for investors seeking to establish a defensive position. However, the absence of strong technical signals and mixed news headlines suggest caution.

Recent News Sentiment Impact: The recent news headlines have had a neutral impact on sentiment, with one positive headline (FDA approval) and one neutral headline (new plugin release). The overall sentiment remains balanced.

Technical Analysis

Trend Direction: Short-term: NEUTRAL Medium-term: RANGE-BOUND Long-term: BEARISH

Support/Resistance Levels:

  • Upper Bollinger Band: $0.08
  • Middle Bollinger Band: $0.06
  • Lower Bollinger Band: $0.05
  • SMA 20: $0.06
  • EMA 12: $0.06

Momentum Signals: RSI (14): 51.30 (neutral) MACD: Bullish (above signal line)

Volume Analysis: Volume trend is down, indicating selling pressure. Institutional interest signals are mixed.

News & Sentiment Analysis

Recent Headlines Summary: One positive headline (FDA approval) and one neutral headline (new plugin release).

Sentiment Assessment: Neutral sentiment due to mixed news headlines.

Catalyst Identification: The FDA approval for Envoy Medical's hearing device is a potential catalyst.

Market Narrative: The market narrative remains uncertain, with no clear direction or momentum.

Risk & Volatility Assessment

Beta Interpretation: Low beta (0.25) indicates low risk relative to the market.

Volatility Regime: Current volatility is low compared to historical levels.

Options Market Signals: No options data available.

Downside Protection: Support levels are at $0.05 and $0.06, which could provide some downside protection.

Market Context & Positioning

Sector Performance: COCHW's performance is in line with the overall market.

Institutional Activity: Mixed institutional interest signals.

Correlation Analysis: R-squared interpretation suggests a moderate correlation between COCHW and the market.

Relative Valuation: COCHW is positioned within its trading range, making it difficult to determine value relative to peers.

Key Levels & Action Items

Critical Price Levels:

  • Support at $0.05 and $0.06
  • Resistance at $0.08 (upper Bollinger Band)

Breakout/Breakdown Levels: No clear breakout or breakdown levels are present.

Time-Sensitive Catalysts: The FDA approval for Envoy Medical's hearing device is a potential catalyst.

Risk Management: Stop-loss levels could be set around the support levels of $0.05 and $0.06, with position sizing considerations based on risk tolerance.

Generated

COCHW Options Activity & IV Rank

Loading options activity...
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis

Risk Metrics

Beta: 4.0781
Alpha: 322.42%
Correlation: 0.1776
R-Squared: 3.2%
Stock Volatility: 308.1%
Market Volatility: 13.4%

Analysis Details

Benchmark: SPY
Data Points: 162
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own COCHW
1 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Rockefeller Capital Management Family office
Rockefeller family
$0K
0.00%
#4697 of 47290.0%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

COCHW Institutional Ownership (13F)

Latest filings — 2026-09-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

33 filers5,799,520 shares$369.87K value
# Filer Shares Value % of Total % of Float Period
1 Oasis Management Co Ltd. 100,000 $79.20K 21.41% — 2026-06-30
2 ARISTEIA CAPITAL, L.L.C. 1,143,978 $54.23K 14.66% — 2026-06-30
3 TORONTO DOMINION BANK 534,600 $26.73K 7.23% — 2026-06-30
4 Athos Capital Ltd 28,588 $23.00K 6.22% — 2026-06-30
5 Sandia Investment Management LP 514,702 $20.02K 5.41% — 2025-12-31
6 Clear Street Group Inc. 301,016 $14.99K 4.05% — 2026-06-30
7 BNP Paribas Financial Markets Custodian 283,333 $14.11K 3.81% — 2026-06-30
8 Polar Asset Management Partners Inc. 297,100 $14.08K 3.81% — 2026-06-30
9 Bracebridge Capital, LLC 262,156 $13.05K 3.53% — 2026-06-30
10 Diametric Capital, LP 236,254 $11.77K 3.18% — 2026-06-30
11 Jane Street Group, LLC Custodian 208,166 $10.37K 2.80% — 2026-06-30
12 SummitTX Capital, L.P. 222,671 $10.02K 2.71% — 2026-06-30
13 Sculptor Capital LP 182,142 $9.07K 2.45% — 2026-06-30
14 WHITEBOX ADVISORS LLC 174,000 $8.66K 2.34% — 2026-06-30
15 MOORE CAPITAL MANAGEMENT, LP 166,666 $8.30K 2.24% — 2026-06-30
16 Vestcor Inc 166,666 $7.00K 1.89% — 2026-06-30
17 Goldman Sachs Group Inc Custodian 125,039 $6.23K 1.68% — 2026-06-30
18 Q Global Advisors, LLC 129,120 $6.00K 1.62% — 2026-06-30
19 D. E. Shaw & Co., Inc. Custodian 113,431 $5.10K 1.38% — 2026-06-30
20 Calamos Advisors LLC 100,000 $4.50K 1.22% — 2026-06-30
21 Silver Rock Financial LP 81,975 $4.08K 1.10% — 2026-06-30
22 Empyrean Capital Partners, LP 75,000 $3.73K 1.01% — 2026-06-30
23 DUPONT CAPITAL MANAGEMENT CORP 100,000 $3.15K 0.85% — 2026-09-30
24 WOLVERINE ASSET MANAGEMENT LLC 54,190 $2.70K 0.73% — 2026-06-30
25 TENOR CAPITAL MANAGEMENT Co., L.P. 50,000 $2.49K 0.67% — 2026-06-30
1 filers$10.34K notional
# Filer Notional Value % of Total Period
1 Millennium Management LLC Custodian $10.34K 100.00% 2026-06-30
# Filer Notional Value % of Total Period

COCHW Insider Trading (Form 4)

Latest: 2026-06-04
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-06-04 Brent T. Lucas Chief Executive Officer Award (A) +32,856 $0.60 $19.7K EDGAR
2026-04-17 Chas McKhann Director Grant (A) +100,000 opt — EDGAR
2026-02-17 Mona Chetan Patel Director Buy (P) +312,500 $0.40 $125.0K EDGAR
2026-02-17 Charles Brynelsen Director Buy (P) +1,000,000 $0.40 $400.0K EDGAR
2026-02-17 Brent T. Lucas Chief Executive Officer Buy (P) +62,500 $0.40 $25.0K EDGAR
2026-02-17 Susan Kantor Director Buy (P) +96,150 $0.40 $38.5K EDGAR
2026-02-17 Robert Potashnick Interim CFO Buy (P) +212,500 $0.40 $85.0K EDGAR
2026-02-17 Glen A Taylor 10%+ Owner Buy (P) +18,750,000 $0.40 $7.50M EDGAR
2026-02-09 Robert Potashnick Interim CFO Grant (A) +15,000 opt — EDGAR
2026-02-09 Brent T. Lucas Chief Executive Officer Award (A) — — EDGAR
2025-12-10 Brent T. Lucas Chief Executive Officer Award (A) +18,105 $0.71 $12.9K EDGAR
2025-12-05 Janis Smith-Gomez Director Grant (A) +25,000 opt — EDGAR
2025-12-05 Mona Chetan Patel Director Award (A) — — EDGAR
2025-12-05 Susan Kantor Director Award (A) — — EDGAR
2025-12-05 Michael Curtis Crowe Director Grant (A) +25,000 opt — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

COCHW Insider Holdings

8 insiders · @ $0.03
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Glen A Taylor Director 26,513,991 $665.5K $7.50M 11 2026-02-17
2 Anzu SPAC GP I LLC 10%+ Owner 2,028,986 $50.9K $0 1 2024-12-26
3 Charles Brynelsen Director 1,050,000 $26.4K $482.4K 4 2026-02-17
4 Whitney Haring-Smith 10%+ Owner 1,000,000 $25.1K $0 1 2024-11-21
5 Brent T. Lucas Chief Executive Officer 342,666 $8.6K $37.0K 9 2026-06-04
6 Mona Chetan Patel Director 332,500 $8.3K $165.5K 7 2026-02-17
7 Robert Potashnick Interim CFO 212,500 $5.3K $85.0K 2 2026-02-17
8 Susan Kantor Director 174,037 $4.4K $38.5K 5 2026-02-17
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.